The Gates Foundation funded 55 grantees worth $269,544,744 in 2014 alone for Pneumonia or Pneumonia-related projects / research, a sign of the efforts that are being taken in the battle against Pneumonia.
Recently The Gates Foundation announced it was funding Novavax with $89 million for 'developing a vaccine to prevent pneumonia' making this the most expensive Pneumonia related grant made by the foundation.
Not A One-Off Effort
The Gates Foundation has so far funded 230 Pnemonia related projects. The visual below is an indication of how much has been spent each year toward this effort & the grantees involved.
Amount Funded Each Year
$33,200,592 funded in 2000 $87,520,483 funded in 2001 $11,458,135 funded in 2002 $4,567,561 funded in 2003 $15,111,531 funded in 2004 $28,470,767 funded in 2005 $77,316,430 funded in 2006 $40,928,417 funded in 2007 $73,169,885 funded in 2008 $107,174,596 funded in 2009 $53,541,915 funded in 2010 $154,595,650 funded in 2011 $120,089,522 funded in 2012 $192,514,826 funded in 2013 $269,544,744 funded in 2014 $188,152,988 funded in 2015 Funds Received By Each Grantee
Novavax was granted $89,000,000 in 2015 Novavax
PATH was granted $87,520,483 in 2001 to support the elimination of epidemic meningitis in Sub-Saharan Africa PATH
PATH Vaccine Solutions was granted $75,000,000 in 2006 to support a portfolio of pneumococcal vaccine projects PATH Vaccine Solutions
Emory University was granted $71,884,810 in 2015 Emory University
PATH Vaccine Solutions was granted $59,570,401 in 2012 to reduce the number of deaths & hospitalizations of infants & children in the developing world due to pneumonia & invasive pneumococcal disease (IPD) by advancing the development of safe effective & affordable new vaccines against S. pneumoniae PATH Vaccine Solutions
International Bank for Reconstruction and Development was granted $50,000,000 in 2009 to create a reliable market that will create incentives for the vaccine industry to onvestments in late-stage development manufacturing scale up and introduction of a pneumococcal vaccine appropriate for use in the developing world International Bank for Reconstruction and Development
Stanford University was granted $49,999,087 in 2014 to establish a state-of-the-art center for immunological analysis at Stanford University with the goal of accelerating global health and vaccine research by bring to bear upon these problems the talents of some of the world leaders in immunology Stanford University
The University of Manitoba was granted $44,240,580 in 2013 to reduce the adverse health and development outcomes to families mothers newborns and children by achieving high reach coverage and quality of effective interventions and services for health (maternal neonatal and child health family planning and
nutrition in communities and at health facilities) agriculture and financial inclusion The University of Manitoba
Johns Hopkins University was granted $40,940,324 in 2008 to support the Pneumonia Etiology Research for Child Health (PERCH) Project Johns Hopkins University
PATH Vaccine Solutions was granted $38,750,000 in 2007 to support research and development of new influenza vaccines to address pandemic influenza PATH Vaccine Solutions
GAVI Alliance was granted $33,000,000 in 2011 GAVI Alliance
PATH Vaccine Solutions was granted $29,689,895 in 2013 to protect infants through RSV maternal immunization PATH Vaccine Solutions
United States Fund for UNICEF was granted $29,294,809 in 2014 to contribute to the reduction of maternal and infant deaths United States Fund for UNICEF
PATH Vaccine Solutions was granted $26,666,502 in 2012 To support efforts to develop a low-cost polysaccharide conjugate vaccine against Streptococcus pneumoniae to reduce childhood morbidity and mortality from lower respiratory infections in low-income regions. PATH Vaccine Solutions
RESULTS Educational Fund Inc. was granted $24,566,382 in 2014 to mobilize resources and improve non-legislative policy across five continents to increase equitable access to priority health interventions for the reduction and prevention of poverty-related diseases World Health Partners was granted $23,350,000 in 2010 to establish a state-wide network of private health providers in Bihar India to improve management of infectious diseases including diarrhea pneumonia tuberculosis and Visceral Leishmaniasis Child Health Research Foundation (CHRF) was granted $22,817,203 in na University of Maryland Baltimore was granted $20,360,592 in 2000 to develop a stealth measles vaccine which can be administered safely to young infants Clinton Health Access Initiative Inc was granted $19,983,755 in 2013 to provide technical assistance to governments in key geographies to facilitate the introduction of new vaccines and expand access to routine vaccines PATH was granted $19,500,000 in 2013 To achieve sustained increases in immunization coverage through support for country-owned country-led policies practices and information system tools that enable evidence-based decision-making. PATH was granted $17,674,694 in 2014 to focus on innovation introduction and reducing policy barriers to service delivery implementation Clinton Health Access Initiative Inc was granted $17,371,290 in 2011 to accelerate introduction of pneumococcal and rotavirus vaccines Arizona State University was granted $15,178,461 in 2005 to develop a live recombinant attenuated Salmonella anti-pneumococcal vaccine for newborns Serum Institute of India was granted $15,000,000 in 2014 to ensure availability and access of 10-valent pneumococcal conjugate vaccine to India and Gavi-eligible countries and other low and middle income countries (LMICs) JSI Research & Training Institute Inc. was granted $15,000,000 in 2009 to identify and improve specific supply chain management practices that enable Community Health Workers to provide treatment to sick children in the community in four countries in sub-Saharan Africa University of California San Francisco was granted $14,854,765 in 2012 to define the role of mass azithromycin treatments as an intervention for reducing childhood morbidity and mortality Save the Children UK was granted $14,359,116 in 2011 to catalyze an intensified effort to save 15 million lives (14 million children and 1 million mothers) by 2015 by creating the conditions necessary to accelerate access to key health and nutrition services PATH was granted $14,296,045 in 2011 to promote evidence-based advocacy that will improve health in low-resource settings particularly in the priorities identified by the health-focused Millennium Development Goals University of Cape Town was granted $14,068,960 in 2011 to support a longitudinal cohort study of children evaluating the number severity and etiology of respiratory disease and evaluate the potential effect modifiers that may influence the incidence and severity of acute lower respitory infections University of Maryland Baltimore was granted $13,337,263 in 2009 to estimate incidence of influenza-like illness and lab confirmed influenza in pregnant and post-partum women and their infants and conduct controlled trials to determine safety and effectiveness of maternal flu vaccine for women and their infants Johns Hopkins University was granted $12,840,000 in 2000 to develop a stealth measles vaccine that is safe and effective in immunizing young infants Cincinnati Children's Hospital Medical Center was granted $12,747,461 in 2008 to field trial maternal influenza immunization in Asia (Mother’s Gift 241 Field Trial) World Health Organization was granted $12,039,172 in 2014 to assess the benefits of an enhanced approach to community case management for pneumonia contributing to the evidence base for revision of WHO/UNICEF integrated community case management (iCCM) tool and its harmonization with the integrated management
of childhood illness (IMCI) tool World Health Organization was granted $11,458,135 in 2002 to evaluate aerosol measles vaccination versus syringe Wits Health Consortium was granted $10,953,984 in 2010 PATH was granted $10,851,639 in 2014 to increase the evidence base regarding the efficacy of vaccination of women during pregnancy against pertussis thereby supporting efforts to make available a potentially high-impact intervention to reduce pertussis in mothers and newborns National Heart Lung and Blood Institute (NHLBI) was granted $10,000,000 in 2015 to develop a research framework to produce a stronger evidence base linking reduction in households air pollution (HAP) exposures to defined health outcomes for populations in Low- and Middle-income countries (LMICs) National Foundation for the Centers for Disease Control & Prevention was granted $9,999,999 in 2013 To develop a regional meningitis surveillance network to evaluate the impact of MenAfriVac introduction in the African Meningitis Belt Johns Hopkins University was granted $9,789,955 in 2014 to help inform evidence-based dialogue and public health policy related to vaccines in India working closely with the Indian Ministry of Health local experts and local partners on including vaccines within comprehensive approaches to protect children
from life-threatening diseases - namely diarrhea pneumonia and meningitis London School of Hygiene and Tropical Medicine was granted $9,649,529 in 2008 to evaluate the impact of a new serogroup A meningococcal conjugate vaccine on pharyngeal carriage and transmission of serogroup A meningococcal infection in countries of the African meningitis belt University of Wisconsin was granted $9,590,589 in 2009 for high-throughput analysis of avian influenza variants for pandemic potential The University of Texas Medical Branch at Galveston was granted $9,456,946 in na PATH was granted $8,941,012 in 2004 to support the development of a safe efficient and cost-effective pneumococcal common protein vaccine Medical Research Council was granted $8,680,182 in 2011 to facilitate the use of pneumococcal vaccines in low-income countries and so reduce child mortality due to pneumococcal disease Management Sciences for Health was granted $8,623,188 in 2011 Fraunhofer USA Inc. was granted $8,597,848 in na National Institute for Health and Welfare was granted $8,097,894 in 2005 to reduce the time and cost for trials of vaccines against bacterial pneumonia Icahn School of Medicine at Mount Sinai was granted $8,050,000 in 2014 PATH Vaccine Solutions was granted $8,000,000 in 2013 to develop safe effective and affordable vaccines for introduction into the developing world Public Health Foundation of India was granted $7,687,120 in 2013 to achieve reductions in morbidity and mortality associated with vaccine-preventable diseases by improving the quality and coverage of the routine immunization program in India and by creating a vaccine delivery system Johns Hopkins University was granted $7,173,351 in 2009 to reduce the burden of childhood pneumonia in a high endemic urban setting through the strategic use of influenza vaccine with the aim of reducing clinical pneumonia hospitalization and other complications Results for Development Institute was granted $6,764,295 in 2014 to increase access to effective treatment for childhood pneumonia by addressing barriers to amoxicillin DT uptake at the supplier country and global levels World Health Organization India Country Office was granted $6,596,997 in 2014 CARE was granted $6,299,343 in 2014 to reduce mortality due to pneumonia and diarrhea in children under five in selected districts in Bihar India through frontline worker and health care provider capacity building and health system strengthening PnuVax Inc. was granted $5,999,614 in 2014 to increase the availability of low-cost PCV-13 to the developing world Johns Hopkins University was granted $5,964,314 in 2013 to conduct a pneumococcal vaccine impact assessment in Bangladesh Emory University was granted $5,954,911 in 2011 NanoBio Corporation was granted $5,930,094 in 2010 to develop an effective stable intranasal nanoemulsion adjuvanted respiratory syncytial virus (RSV) vaccine for the developing world without the hyper-reactivity observed with prior RSV vaccines in clinical trials Johns Hopkins University was granted $5,856,220 in 2010 to support the development of a comprehensive approach to the disease burden of pneumonia and diarrhea in children under age 5 in India University of Nebraska Medical Center was granted $5,836,888 in 2011 to promote the prevention of pneumonia bacteremia sepsis and meningitis in young Nigerian children by providing support for the creation of a platform for generating credible local burden and incidence data World Health Organization was granted $5,654,305 in 2009 to support H1N1 vaccine logistics Broad Institute was granted $5,434,166 in 2009 to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test Wits Health Consortium was granted $5,408,262 in 2014 Pact Institute was granted $5,355,112 in 2013 to increase care-seeking behaviors for childhood illness in select high burden Nigerian states by addressing demand creation and supply of essential medicines to treat diarrhea Columbia University was granted $5,187,505 in 2008 to determine the causes of pediatric pneumonia in The Gambia using molecular tools for viral and bacterial surveillance and discovery to inform prioritization of microbial targets for vaccine development Terre des Hommes Foundation was granted $5,000,000 in 2013 to improve the management of febrile illness in children under five World Health Organization was granted $4,999,773 in 2013 to build a maternal immunization platform in conjunction with antenatal care in low and middle-income countries World Health Organization was granted $4,994,168 in 2014 to ensure that those living in countries across the African meningitis belt are protected against invasive meningococcal disease caused by group A Neisseria meningitidis (Meningitis A) in a sustainable manner and to improve the response to meningitis outbreaks
and strengthen global understanding of the disease Murdoch Childrens Research Institute was granted $4,992,818 in 2014 PATH was granted $4,989,166 in 2014 to contribute to the elimination of meningococcal meningitis epidemics as a public health problem in sub-Saharan Africa University of Oxford was granted $4,775,354 in 2012 to improve and facilitate clinical research in developing countries by creating a platform for organizations to share research and information Murdoch Childrens Research Institute was granted $4,771,414 in 2015 Agence de was granted $4,709,280 in 2011 University of Maryland Baltimore was granted $4,222,128 in 2004 to introduce and monitor the effects of Haemophilus influenzae type b (Hib) conjugate vaccine in high-risk infant populations in Mali West Africa World Health Organization was granted $4,218,402 in 2003 to support a project to control Epidemic Meningococcal Disease Surveillance in the African Meningitis Belt BBC Media Action was granted $4,179,158 in 2013 to implement an effective integrated and sustainable multi-channel communication strategy to increase early care-seeking for childhood pneumonia and diarrhea in two Northern Nigerian states Hospital for Sick Children was granted $3,933,730 in 2012 to contribute new knowledge regarding causes of fetal and early infant under nutrition in resource-poor settings and to identify novel targets of intervention to improve child growth before age two World Health Organization was granted $3,904,574 in 2014 to advance global standards and norms for respiratory syncytial virus (RSV) vaccine development WHO prequalification and ultimately use of RSV vaccines to protect kids in low and middle income countries United States Fund for UNICEF was granted $3,749,619 in 2013 to assess the feasibility and costs and benefits of integrating the diagnosis and treatment of pneumonia into large-scale malaria programs Emory University was granted $3,632,353 in 2014 Jackson Laboratory was granted $3,550,000 in 2011 to understand the impact of pneumococcal conjugate vaccine (PCV) to nasopharynx microbiome in Africa and Southeast countries J. Craig Venter Institute was granted $3,500,051 in 2011 to use new molecular technologies to elucidate the nasopharyngeal microbiome in GEMS & PERCH sites where factors such as ethnicity environment and disease state can influence the composition of the microbiome as a basis for evaluating PCV impact INCLEN Inc. was granted $3,368,776 in 2013 PnuVax Inc. was granted $3,298,464 in 2015 to evaluate efficiency of PnuVax's novel conjugation chemistry for making pneumococcal conjugate vaccine.. Malaria Consortium was granted $3,273,903 in 2013 Duke University was granted $3,267,474 in 2011 to evaluate the social franchising and telemedicine project on engaging with private sector providers in Bihar India Murdoch Childrens Research Institute was granted $3,254,644 in na PATH was granted $3,211,791 in 2005 to measure the impact of Hib vaccine introduction in Senegal Center for Disease Dynamics Economics & Policy was granted $3,211,449 in 2011 to fund a project that will build capacity and develop tools for low- and middle-income countries to use antibiotics appropriately Murdoch Childrens Research Institute was granted $3,096,211 in 2013 Children's Hospital Boston was granted $3,062,212 in 2012 to develop a bivalent vaccine by conjugating a fusion of three novel highly-conserved pneumococcal antigens to the already approved Vi polysaccharide vaccine used for typhoid Wits Health Consortium was granted $3,060,440 in 2014 PATH was granted $2,999,661 in 2014 to build evidence regarding the ideal duration of treatment with amoxicillin dispersible tablets (DT) for fast-breathing and chest-indrawing childhood pneumonia in malaria-endemic settings in Africa Murdoch Childrens Research Institute was granted $2,994,783 in 2014 Johns Hopkins University Bloomberg School of Public Health Center for Communication Programs was granted $2,832,546 in 2014 Cardiff University was granted $2,764,370 in 2015 Duke University was granted $2,707,711 in 2011 to identify biomarkers for the non-invasive discrimination between bacterial and viral pneumonia in children University of Washington Foundation was granted $2,697,432 in 2014 to design produce characterize and assess the immunogenicity of nanoparticles of multiple specific symmetries that present the prefusion forms of human respiratory syncytial virus (hRSV) F and human metapneumonia virus (hMPV) F to potentially generate
novel vaccine design concepts for hRSV/hMPV vaccines suitable for maternal immunization Fraunhofer USA Inc. was granted $2,663,930 in na Liverpool School of Tropical Medicine (LSTM) was granted $2,518,294 in 2014 to determine if live attenuated influenza vaccine (LAIV) or trivalent influenza vaccine (TIV) affects the density and / or duration of pneumococcal colonization in healthy adults using the EHPC (Experimental Human Pneumococcal Carriage) model PATH Vaccine Solutions was granted $2,500,000 in 2013 to reduce morbidity and mortality among infants and children in the developing world due to influenza both seasonal and pandemic by advancing the development of safe effective and affordable new vaccines against influenza virus that are suitable for
use in infants and young children. Johns Hopkins University was granted $2,381,694 in 2014 to provide critical evidence about the population impact of a highly promising pneumococcal conjugate vaccine PCV10 on radiologically and ultrasound confirmed pneumonia in rural Bangladesh World Health Organization was granted $2,196,319 in 2014 to develop more specific criteria for diagnosis and prognostic indicators for pneumonia in under 5 year old children PATH Vaccine Solutions was granted $2,182,670 in 2006 to conduct a landscape analysis of potential pandemic flu vaccine technologies University College London was granted $2,164,081 in 2011 to study the pattern and severity of childhood pneumonia before and after pneumococcal vaccination evaluate the vaccine status of children with severe illnesses and analyze the cost effectiveness of the pneumococcal vaccine in Malawi Center for Disease Dynamics Economics & Policy was granted $2,061,024 in 2008 to identify evaluate and define policy solutions and opportunities to address the challenge of drug resistant bacterial infections Bloomberg School of Public Health was granted $2,043,788 in 2014 to contribute to the reduction of pneumonia and child mortality by supporting the optimum use and implementation of pneumococcal conjugate vaccine (PCV) Agence de was granted $2,032,736 in 2013 World Health Organization was granted $1,902,329 in 2010 to help countries take advantage of increased attention to child health rising out of the Millennium Development Goals and programs such as the USG Global Health Initiative to improve implementation of interventions against pneumonia and diarrhea United Nations Foundation was granted $1,900,000 in 2004 to strengthen immunization services in Africa through measles mortality reduction The University of Edinburgh was granted $1,841,471 in 2008 to develop a tool that will enable comparative assessment of expected returns on investments in: (i) development of new interventions and (ii) scaling up the existing interventions against childhood pneumonia PATH Vaccine Solutions was granted $1,782,978 in 2011 to assess the capacity of six China National Biotec Group institutes to meet World Health Organization requirements for priority vaccines to improve their potential to provide safe effective and affordable vaccines Liverpool School of Tropical Medicine (LSTM) was granted $1,741,843 in 2014 to generate evidence and a prediction model to inform vaccine scheduling and the design of alternative Pneumococcal conjugate vaccine regimens focused on reducing carriage person-to-person transmission and optimizing herd protection from disease Vanderbilt University was granted $1,597,295 in 2010 to support a respiratory syncytial virus burden of disease study Novartis Vaccines and Diagnostics S.r.l was granted $1,537,375 in 2013 to build capacity in Vaccinology and Vaccine Clinical Development in developing countries with the aim to contribute to public health and policy making focused on the immunization field at large CORDS Association was granted $1,500,000 in 2012 University of California San Francisco was granted $1,499,931 in 2012 to establish the basis for effective and large-scale engagement of PPMVs to improve management of childhood diarrhea pneumonia and malaria in Nigeria University of Liverpool was granted $1,499,862 in 2010 to enable and drive the development of improved and appropriate vaccines against invasive pneumococcal disease for use in high burden low income countries Yale University was granted $1,499,205 in 2014 to assess PCV impact among lower- and higher-income populations in three middle-income countries World Health Organization was granted $1,498,947 in 2011 to support a project that will focus on a review of the evidence base for the current recommended immunization schedule with the understanding that any changes in the schedule are inappropriate without strong evidence to demonstrate benefit Vanderbilt University was granted $1,496,536 in 2013 to research the acute and long term consequences of RSV infection in children United States Fund for UNICEF was granted $1,495,587 in 2014 to support efforts in reducing mortality due to pneumonia diarrhea and malaria among children under five years old living in hard to reach areas by expanding the reach of the Integrated Community Case Management (iCCM) in Nigeria Research Triangle Institute was granted $1,494,160 in 2012 to develop an optimized RTI MicroPEM for young children in IAP settings. PATH was granted $1,463,718 in 2005 to complete a study of pneumococcal conjugate vaccine for children in the Philippines The Alliance for the Prudent Use of Antibiotics Inc. was granted $1,432,856 in na World Health Organization was granted $1,299,500 in 2013 to optimize the process of WHO biannual influenza vaccine virus selection towards appropriate influenza vaccine composition recommendations for tropical countries University of Wisconsin was granted $1,291,332 in 2007 to create high-throughput systems to generate and screen influenza viral protein libraries for biologically functional proteins Kenya Medical Research Institute was granted $1,290,115 in 2011 to support a study on pneumococcal conjugate vaccine (PCV) impact in Kenya that will provide information relevant to supporting sustained vaccine use in Kenya and encourage introduction of PCV in other countries in sub-Saharan Africa Boston University was granted $1,175,931 in 2014 to measure the burden of severe and non-severe pertussis disease among young African infants in a setting of very high maternal HIV seroprevalence Child Health Research Foundation (CHRF) was granted $1,075,583 in 2013 World Health Organization was granted $1,040,124 in 2014 to more rapidly increase global pandemic influenza preparedness and health security by securing real-time access to pandemic influenza vaccines for countries in need at the time of a pandemic Liverpool School of Tropical Medicine (LSTM) was granted $998,437 in 2011 to further refine and evaluate the reproducibility of the Experimental Human Pneumococcal Carriage PATH was granted $996,595 in 2014 to understand the need and necessary inputs for the development of a reliable robust and scalable oxygen concentrator platform technology to accelerate oxygen delivery in low-resource settings. Brighton Collaboration was granted $987,621 in 2015 Lovelace Respiratory Research Institute was granted $970,979 in 2013 to test the hypothesis that exposure to hardwood smoke will lead to increased density of Streptococcus pneumoniae in colonized individuals University College London was granted $968,889 in 2015 to evaluate the immunogenicity and impact of a reduced 13 valent pneumococcal conjugate vaccine (PCV13) dosing schedule London School of Hygiene and Tropical Medicine was granted $917,380 in 2011 for protein glycan coupling technology and the development of novel conjugate vaccines Johns Hopkins University was granted $906,539 in 2012 To provide technical assistance to develop a research plan for the impact evaluation of pneumococcal conjugate vaccine in India King George's Medical University was granted $897,367 in 2014 to estimate the incidence of radiological pneumonia in children under five years of age in Uttar Pradesh and Bihar states of India which would give the magnitude of burden of pneumonia Emory University was granted $807,988 in 2014 Inventox Inc. was granted $804,741 in 2011 Center for Disease Dynamics Economics & Policy was granted $800,006 in 2014 to establish a global repository of current antimicrobial use and susceptibility/resistance data in order to make it available to policymakers journalists researchers and the public to help understand geographical and temporal variations in antimicrobial
resistance and use Clinton Health Access Initiative Inc was granted $798,633 in 2012 To support new vaccine introductions and the concurrent introduction of pneumococcal and rotavirus vaccines in Tanzania through technical assistance strengthening the capacity of the government to effectively execute Cincinnati Children's Hospital Medical Center was granted $785,326 in 2009 to evaluate the effect of pneumococcal conjugate vaccine given in the routine infant schedule Wits Health Consortium was granted $779,384 in 2014 Rutgers University Foundation was granted $750,000 in 2015 Agence de was granted $732,976 in na The University of Edinburgh was granted $732,248 in 2013 to improve current global estimates of morbidity and mortality due to RSV–associated acute lower respiratory infections in young children INCLEN Inc. was granted $722,704 in 2011 Aga Khan University was granted $674,373 in 2015 to develop five operations research proposals that take a comprehensive approach to addressing maternal newborn and child health across the continuum in Pakistan.. Johns Hopkins University was granted $665,685 in 2010 to conduct an evidence-based rigorous and transparent process for collecting analyzing and interpreting the evidence for pneumococcal serotype replacement World Health Organization was granted $625,815 in 2014 to contribute to the reduction of pneumonia and child mortality by supporting the optimum use and implementation of pneumococcal conjugate vaccine The Task Force for Global Health Inc. was granted $622,196 in 2013 to fund a partnership for influenza vaccine introduction in low and lower middle-income countries University of Southampton was granted $586,460 in 2015 World Health Organization was granted $581,376 in 2013 to convene international stakeholders in order to plan and prepare transition of meningitis A vaccinations from campaigns to routine systems in countries of the African meningitis belt Johns Hopkins University was granted $562,857 in 2010 to evaluate the accuracy of diagnosis of ALRI and severe ALRI when standardized measurement and interpretation of chest auscultation is included as a diagnostic technology University of Washington was granted $550,470 in 2007 to provide information on the potential cost-effectiveness of additional investments in several ongoing vaccine-improvement initiatives aimed at reducing the global disease burden of measles Research Triangle Institute was granted $489,725 in 2012 to provide general operating support to RTI an independent nonprofit institution that provides research development and technical services to government and commercial clients worldwide. University of Oxford was granted $486,927 in 2014 to facilitate the necessary infrastructure and collaborative platform for an efficient global clinical research response to respiratory infection outbreaks and pandemic preparedness Fundacio Clinic per a la Recerca Biomedica was granted $486,449 in na Duke University was granted $426,990 in 2010 to plan for evaluation of a project designed to engage private health providers to improve management of infectious diseases in Bihar India Aga Khan University was granted $424,276 in 2014 to measure the indirect effect of PCV10 in children less than 2 years of age in a rural community in Matiari Sindh Pakistan PATH Vaccine Solutions was granted $399,927 in 2014 to support an assessment of the feasibility and resource requirements for developing a group B streptococcus vaccine University of Colorado Denver was granted $383,635 in 2008 to identify the most sensitive and specific method for detecting viruses causing acute lower respiratory infections in Philippine children by testing different multiplex PCR methods to complement global epidemological studies University Health Network was granted $374,713 in 2012 To identify biomarkers that could be used in low resource settings to reliably identify children with life-threatening infections requiring antimicrobial therapy Harvard University was granted $358,936 in 2008 to examine the potential health impact and cost-effectiveness of new diagnostic tools for pneumonia and malaria in African countries King George's Medical University was granted $356,560 in 2013 to improve household decision-making for the management of pediatric pneumonia in Uttar Pradesh and Bihar India Murdoch Childrens Research Institute was granted $349,992 in 2015 Johns Hopkins University was granted $349,159 in 2003 to evaluate the effect of high levels of maternal antibody on the infant's response to pneumococcal conjugate vaccine given in the routine infant schedule University of Liverpool was granted $343,147 in 2015 to estimate the effect of indoor air pollution and its reduction on pneumococcal nasopharyngeal carriage University of British Columbia was granted $331,926 in 2015 to support assessment of research needed to address critical questions on immunology in pregnant women and neonates to understand the effect of the immune response in pregnancy and neonates on the safety and efficacy of maternal immunization Johns Hopkins University School of Medicine was granted $319,786 in 2015 Vanderbilt University was granted $307,296 in 2015 to document the role that maternal immunization will have in providing protective antibody levels to tetanus diphtheria and pertussis (Tdap) antigens to their infants and to assess the mechanism of local and systemic reactions to Tdap if they would occur Griffith University was granted $304,368 in 2014 to rapidly accelerate the development of “pneumonia” journal and ensure free and open access to the journal’s contents especially to the research community in the developing world Center for Disease Dynamics Economics & Policy was granted $300,000 in 2011 to hold the first international forum in a developing country on antibiotic access and resistance with a focus on pneumonia in low and middle-income countries Johns Hopkins University was granted $295,681 in 2013 to conduct a digital auscultation study of pneumonia etiology research for child health Johns Hopkins University was granted $294,422 in 2005 to evaluate the effect of pneumococcal conjugate vaccine given in the routine infant schedule American Society of Tropical Medicine and Hygiene was granted $291,215 in 2010 for conference support for annual meetings of the American Society of Tropical Medicine and Hygiene Lovelace Respiratory Research Institute was granted $274,551 in 2013 for general operating support in association with OPP1067751 "Pneumococal Nasal Colonization and Wood Smoke Exposure: A Human Exposure Study" Rutgers University Foundation was granted $267,896 in 2014 World Health Organization was granted $265,075 in 2011 to support convenings in order to update WHO guidance on improved tools and standards for SPn studies and PCV impact evaluation World Health Organization was granted $260,031 in 2014 to bring together stakeholders from different disciplines to discuss potential risks and benefits of immunizing children between 6 months and 2 years of age in low- and middle-income countries (LMICs) with live-attenuated influenza vaccine (LAIV) PATH was granted $251,149 in 2014 to conduct a landscape analysis assessing the current knowledge gaps operational barriers and opportunities for implementing antenatal pertussis immunization programs in low-resource countries. University College London was granted $251,100 in 2015 to support the International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) the international pneumococcal experts meeting which is at the forefront all new evidence regarding pneumococcal disease and its prevention which will be held in Glasgow
Scotland in June 2016 IDSA Education and Research Foundation was granted $247,370 in na University of Oxford was granted $230,127 in 2011 To support the creation of a multi-regional consortium of hospital-based networks able to perform collaborative clinical research during epidemics of severe acute respiratory infections London School of Hygiene and Tropical Medicine was granted $229,861 in 2011 to convene a meeting of experts in meningococcal disease to determine how to monitor the long-term impact of meningococcal vaccines in Africa Center for Biologics Evaluation and Research FDA was granted $215,607 in 2014 Fondation Merieux was granted $210,081 in 2005 to support a meeting on "Challenges in the African Meningitis Belt: From Genomics to Prevention Strategies" International Society for Influenza and other Respiratory Virus Diseases was granted $200,000 in 2013 to promote international and multidisciplinary collaboration while supporting influenza research by supporting the Options for the Control of Influenza VIII conference International Centre for Diarrhoeal Disease Research Bangladesh was granted $199,596 in 2009 to estimate the contribution of Respiratory Syncytial Virus (RSV) to mortalitiy associated with acute lower respiratory tract illness in developing countries and to determine the need for development of a safe and effective RSV vaccine ISPPD Association was granted $196,585 in 2013 American Society for Microbiology was granted $161,460 in 2015 International Society for Infectious Diseases was granted $161,230 in 2015 to support the International Conference on Infectious Diseases (ICID) sponsored by the International Society of Infectious Diseases (ISID) will be held on March 2-5 2016 in Hyderabad India World Health Organization was granted $159,659 in 2011 to support the Expanded Programme on Immunization to convene an international consultation to review the results of a systematic analysis of data and establish criteria for interpreting surveillance data regarding pneumococcal vaccines PATH Vaccine Solutions was granted $155,039 in 2013 To support the Respiratory Syncytial Virus (RSV) Vaccine Forum and Live Attenuated Influenza Vaccine (LAIV) Clinical Data Review Meeting World Health Organization was granted $150,000 in 2010 to provide conference support for an international forum on vaccine R&D issues with leading scientists and representatives of vaccine industry from developed & developing countries London School of Hygiene and Tropical Medicine was granted $131,330 in 2015 to improve understanding of how conjugate vaccines impact pneumococcal ecology and to inform how vaccines of higher valences can be most effectively used to reduce the burden of pneumococcal illness World Health Organization was granted $120,000 in 2010 to provide conference support for meetings regarding the evaluation of pandemic influenza vaccines in clinical trials Cincinnati Children's Hospital Medical Center was granted $103,985 in 2007 to analyze paired mother infant sera from HIV positive mothers to determine the effectiveness of trans-placental antibody transfer for vaccine preventable diseases (flu pneumo and tetanus) International Society for Influenza and other Respiratory Virus Diseases was granted $100,942 in 2010 for general operating support Foundation for the National Institutes of Health was granted $100,000 in 2007 to convene a summit of G7 and Mexico Health Ministers to strengthen health preparedness and response to threats of biological chemical radiological and nuclear terrorism and outbreaks of pandemic influenza and other infectious disease South African Society for Paediatric Infectious Diseases was granted $99,940 in 2014 The Royal Institute of International Affairs was granted $99,666 in 2013 to convene an international meeting and follow-up roundtables in order to identify the best ways to combat antimicrobial resistance. National Foundation for the Centers for Disease Control & Prevention was granted $95,134 in 2014 to support influenza research activities in Africa educate African scientists on influenza epidemiology and laboratory science and establish the burden of influenza disease for future vaccine deployment among pregnant women young children or other
risk groups Engineering Conferences International Inc. was granted $88,322 in 2010 to support the Vaccine Technology III conference that addresses process engineering techonolgy aspects of vaccine production and how the vaccine development cycle integrates with regulatory issues clinical development and public policy ESWI was granted $85,000 in 2014 National Bureau of Asian Research was granted $84,040 in 2006 to support a conference entitled "Avian Influenza Vaccines: Building a Model for Global Collaboration" Engineering Conferences International Inc. was granted $75,000 in 2012 to provide scientists and public policy makers from developing countries with the opportunity to attend the Vaccine Technologies IV conference and learn vaccine development The Royal Institute of International Affairs was granted $69,000 in 2007 to demonstrate and review an approach for prevention and control of global Avian and Human Influenza pandemic with specific focus on access to preventative measures by low-income countries Gordon Research Conferences was granted $63,630 in 2007 to convene a conference of acute lower respiratory infection researchers with the strategic approach of accelerating discovery by scientists working to create health tools such as vaccines drugs and diagnostics Gordon Research Conferences was granted $60,000 in 2014 to convene an international conference on the biology of acute respiratory infections a leading cause of morbidity and mortality in the world University of Oxford was granted $56,192 in 2014 to organize workshop to provide a platform for discussion on the potential risks and benefits of novel vaccination strategies for respiratory syncytial virus (RSV) and to define the criteria for advancing vaccine studies in different populations Albert B. Sabin Vaccine Institute Inc. was granted $50,000 in 2014 to support the Sabin Vaccine Institute 20th Anniversary Scientific Symposium to convene experts from around the world to examine key lessons from recent efforts to address pressing global health challenges and share insights on emerging immunization trends. Medical Research Council was granted $50,000 in 2015 to support a global meeting on neonatal and maternal immunization to be held in the Gambia in March 2015 American Society for Microbiology was granted $50,000 in 2011 University of Oxford was granted $49,720 in 2015 to provide support for developing country investigators to attend major biannual conference on meningitis Johns Hopkins University was granted $49,720 in 2006 to support a conference entitled "Vaccines for viruses in developing countries" Arizona State University was granted $48,391 in 2004 to assess the advantage of plant-derived vaccines as an inexpensive technique compared to traditional production methods Gordon Research Conferences was granted $46,120 in 2010 to convene the Gordon Research Conference of acute lower respiratory infection researchers with the strategic approach of accelerating discovery by scientists working to create health tools such as vaccines drugs and diagnostics Gordon Research Conferences was granted $45,000 in 2011 to support the third conference on the Biology of Acute Respiratory Infection University of Iowa was granted $43,351 in na Boston University was granted $41,457 in 2014 to prepare for a site inspection at the Lusaka Zambia research site in preparation for activities related to testing whether passive maternal immunity resulting from maternal Tdap will provide an effective bridge between birth and when infants are able
to mount their own immune responses to vaccines. American Friends of the Royal Society was granted $32,382 in 2012 To convene an international symposium in order to discuss the practice and policy of H5N1 influenza research. World Health Organization was granted $30,475 in 2012 for conference support Albert B. Sabin Vaccine Institute Inc. was granted $25,000 in 2012 for general operating support The Henry M. Jackson Foundation for the Advancement of Military Medicine was granted $14,710 in 2014 to highlight cutting edge research and areas of research need in basic and translational science on the pathogenic Neisseria National Academy of Sciences was granted $14,400 in 2005 to support the John. R. LaMontagne Memorial Symposium on Pandemic Influenza Research Wildlife Disease Association was granted $12,000 in na American College of Obstetricians and Gynecologists was granted $9,600 in 2015 to support a maternal immunization session at the World Congress of Gynecology and Obstetrics
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
50,000,000
100,000,000
150,000,000
200,000,000
250,000,000
20,000,000
40,000,000
60,000,000
80,000,000
Each bar is a year differentiated by a unique color. The height indicates the amount of money granted to institutes, universities or organisations each year for pneumonia or pneumonia-related projects / research. Hovering on a bar highlights the grants awarded in a particular year.
Each circle is a grantee colored by the year in which the grant was awarded & the size indicates the amount. Hovering on a grantee highlights other occassions where the same grantee received grants for pneumonia or pneumonia-related projects / research.
PATH Vaccine Solutions an affiliate of PATH has on the whole received the most funding from the Gates Foundation to research pneumonia & pneumonia related issues. Johns Hopkins University , Emory University & the World Health Organization are amongst the top five to receive the most funding from the Gates Foundation.
Data Courtesy: The Gates Foundation
|
|